7900 ICP-MS Increases Efficiency - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

7900 ICP-MS Increases Efficiency


Pharmaceutical Technology
Volume 38, Issue 3, pp. 14

The 7900 ICP-MS from Agilent Technolgies is a redesign of the 7700 Series. The instruments high-matrix technology allows laboratories to measure samples containing up to 25% total dissolved solids. This is 10 times higher than the current benchmark held by the 7700 ICP-MS, according to the company. The 7900’s new interface design, expansion-stage vacuum system, and orthogonal detector system (ODS) reduce background and improve sensitivity, improving signal to noise for 10-fold lower detection limits, according to the company. The patented ODS technology delivers up to 11 orders of magnitude dynamic range, from sub-ppt to percent-level concentrations, which enables users to measure trace elements and majors in the same run. In addition, the redesigned MassHunter software features a simpler user interface along with increased method automation capabilities.

Agilent Technologies

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here